Most cited papers from Weisenthal Cancer Group

Weisenthal Cancer Group

What are the most cited papers from Weisenthal Cancer Group?

The most cited paper from Weisenthal Cancer Group is "Chemotherapy sensitivity and resistance testing: to be “standard” or to be individualized, that is the question" (Tetsuro Kubota, Larry M. Weisenthal, 2006), with 22 citations. Next come "Differential Staining Cytotoxicity Assay: A Review" (11) and "Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral blood" (10).

Published TypeFieldAccess

Showing 11 of 11 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Chemotherapy sensitivity and resistance testing: to be “standard” or to be individualized, that is the question Tetsuro Kubota, Larry M. Weisenthal · Gastric Cancer Open access	7 Jun 2006	22
2	Differential Staining Cytotoxicity Assay: A Review Larry M. Weisenthal · Methods in molecular biology Book chapter	2011	11
3	Cell culture detection of microvascular cell death in clinical specimens of human neoplasms and peripheral blood Larry M. Weisenthal, Neel Patel, Constance Rueff-Weisenthal · Journal of Internal Medicine Open access	8 Aug 2008	10
4	Clinical Correlations for Cell Culture Assays Based on the Concept of Total Tumor Cell Kill Larry M. Weisenthal · Contributions to gynecology and obstetrics Book chapter	1994	7
5	Bevacizumab-induced tumor calcifications can be elicited in glioblastoma microspheroid culture and represent massive calcium accumulation death (MCAD) of tumor endothelial cells Larry Weiseenthal, Summer Williamson, Cindy Brunschwiler et al. · Nature Precedings Open access	2 Apr 2012	5
6	Antineoplastic activity of idazoxan hydrochloride Gabriel Eilon, Larry M. Weisenthal, Marie Stupecky et al. · Cancer Chemotherapy and Pharmacology Open access	23 Mar 2009	4
7	Death of human tumor endothelial cells in vitro through a probable calcium-associated mechanism induced by bevacizumab and detected via a novel method Larry M. Weisenthal, Haddy Liu, Constance Rueff-Weisenthal · Nature Precedings Open access	28 May 2010	3
8	Cytogenetics, Immunostaining for Fibroblast Growth Factors, p53 Sequencing, and Clinical Features of Two Cases of Cystosarcoma Phyllodes Paul V. Woolley, Susanne M. Gollin, Waheeb Riskalla et al. · Molecular Diagnosis	Sep 2000	2
9	Individualized Tumor Response (ITR) Profiling for Drug Selection in Tailored Therapy: Meta-Analysis of 1929 Cases of Leukemia and Lymphoma. Andrew G. Bosanquet, Gertjan J.L. Kaspers, Rolf L. Larsson et al. · Blood Review	16 Nov 2007	2
10	Endothelial Massive Calcium Accumulation Death (MCAD): Mechanism, Target, and Predictive Biomarker for Anti-Angiogenic Therapy Larry M. Weisenthal · Nature Precedings Open access	28 Nov 2011	2
11	Response L. M. WEISENTHAL · JNCI Journal of the National Cancer Institute Open access	19 Aug 1992	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.